| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 10 | 2022 | 1577 | 1.630 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 94 | 1.530 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2018 | 70 | 1.440 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 503 | 1.390 |
Why?
|
| RNA Helicases | 2 | 2022 | 70 | 1.380 |
Why?
|
| Receptors, Androgen | 4 | 2023 | 410 | 1.230 |
Why?
|
| Inflammation | 5 | 2022 | 1526 | 1.030 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2018 | 137 | 1.000 |
Why?
|
| Prostate | 6 | 2014 | 437 | 0.940 |
Why?
|
| Neoplasms | 5 | 2023 | 2944 | 0.940 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2023 | 200 | 0.940 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 18 | 0.830 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 343 | 0.830 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2022 | 12 | 0.780 |
Why?
|
| Guanidines | 1 | 2022 | 23 | 0.780 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 46 | 0.770 |
Why?
|
| Keto Acids | 1 | 2022 | 56 | 0.770 |
Why?
|
| Transaminases | 1 | 2022 | 36 | 0.760 |
Why?
|
| Stromal Cells | 6 | 2014 | 303 | 0.740 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 26 | 0.720 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 38 | 0.720 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 306 | 0.680 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2023 | 2064 | 0.650 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 375 | 0.640 |
Why?
|
| Transforming Growth Factor beta | 4 | 2014 | 475 | 0.640 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 309 | 0.610 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 350 | 0.610 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 273 | 0.580 |
Why?
|
| Alpharetrovirus | 1 | 2018 | 5 | 0.570 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 138 | 0.550 |
Why?
|
| Retroviridae | 1 | 2017 | 194 | 0.510 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 3693 | 0.500 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 106 | 0.500 |
Why?
|
| Mice | 18 | 2022 | 18559 | 0.480 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1757 | 0.410 |
Why?
|
| Animals | 21 | 2022 | 34947 | 0.390 |
Why?
|
| Mice, SCID | 2 | 2022 | 604 | 0.320 |
Why?
|
| Signal Transduction | 5 | 2023 | 4724 | 0.320 |
Why?
|
| Androgens | 3 | 2023 | 277 | 0.300 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 2681 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 634 | 0.290 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 256 | 0.280 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 53 | 0.270 |
Why?
|
| Proteins | 4 | 2014 | 1060 | 0.250 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 59 | 0.230 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 133 | 0.230 |
Why?
|
| Carcinoma | 1 | 2007 | 300 | 0.220 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 295 | 0.210 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 23 | 0.190 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 725 | 0.190 |
Why?
|
| Humans | 21 | 2023 | 132202 | 0.190 |
Why?
|
| Micrococcal Nuclease | 1 | 2001 | 4 | 0.180 |
Why?
|
| Staphylococcus | 1 | 2001 | 68 | 0.180 |
Why?
|
| Cell Line | 4 | 2021 | 2729 | 0.180 |
Why?
|
| Protein Isoforms | 1 | 2022 | 422 | 0.180 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 143 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2021 | 3873 | 0.170 |
Why?
|
| Protein Conformation | 3 | 2003 | 823 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 1047 | 0.170 |
Why?
|
| Th17 Cells | 1 | 2021 | 98 | 0.160 |
Why?
|
| Th1 Cells | 1 | 2021 | 159 | 0.160 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 142 | 0.160 |
Why?
|
| Kupffer Cells | 1 | 2020 | 21 | 0.160 |
Why?
|
| Cell Survival | 1 | 2022 | 869 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 364 | 0.160 |
Why?
|
| Mice, Nude | 5 | 2014 | 757 | 0.160 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 61 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 667 | 0.160 |
Why?
|
| Hepatitis | 1 | 2020 | 58 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2022 | 998 | 0.160 |
Why?
|
| Male | 15 | 2023 | 65011 | 0.160 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 513 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 447 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4765 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 234 | 0.150 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 189 | 0.150 |
Why?
|
| DNA Damage | 1 | 2021 | 513 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2021 | 796 | 0.140 |
Why?
|
| DNA Repair | 1 | 2021 | 567 | 0.140 |
Why?
|
| Luciferases | 1 | 1997 | 129 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 4 | 2007 | 257 | 0.140 |
Why?
|
| Transplantation, Heterologous | 3 | 2007 | 273 | 0.130 |
Why?
|
| Calcium | 1 | 2022 | 1082 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 4679 | 0.130 |
Why?
|
| Oncogenes | 1 | 2018 | 175 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2014 | 134 | 0.130 |
Why?
|
| Ribosomes | 1 | 1997 | 125 | 0.130 |
Why?
|
| Mitochondria | 1 | 2022 | 751 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 112 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 114 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 241 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2021 | 745 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 8 | 0.110 |
Why?
|
| Pteridines | 1 | 2014 | 12 | 0.110 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 15 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2017 | 527 | 0.110 |
Why?
|
| Kallikreins | 1 | 2014 | 31 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2020 | 703 | 0.110 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 422 | 0.110 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 38 | 0.110 |
Why?
|
| Myofibroblasts | 1 | 2014 | 68 | 0.110 |
Why?
|
| Benzamides | 1 | 2014 | 124 | 0.110 |
Why?
|
| Nitriles | 1 | 2014 | 155 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2014 | 237 | 0.110 |
Why?
|
| Disease Progression | 2 | 2013 | 2225 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2449 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 272 | 0.100 |
Why?
|
| beta Catenin | 1 | 2015 | 227 | 0.100 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 152 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2014 | 438 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 326 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 1083 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 543 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 468 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2015 | 359 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1292 | 0.090 |
Why?
|
| Apoptosis | 2 | 2017 | 1901 | 0.090 |
Why?
|
| Ganglia | 1 | 2010 | 16 | 0.090 |
Why?
|
| Wound Healing | 1 | 2014 | 480 | 0.080 |
Why?
|
| Macrophages | 1 | 2014 | 692 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2014 | 2686 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2013 | 1569 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2005 | 124 | 0.070 |
Why?
|
| Female | 3 | 2022 | 70742 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 590 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 123 | 0.070 |
Why?
|
| Liver | 1 | 2015 | 1815 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2511 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1540 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 688 | 0.060 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2005 | 21 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 503 | 0.050 |
Why?
|
| HIV-1 | 1 | 2007 | 480 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2003 | 64 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 14 | 0.050 |
Why?
|
| Muramidase | 1 | 2003 | 91 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1257 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 173 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 1253 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2003 | 1116 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 69 | 0.040 |
Why?
|
| Radioimmunotherapy | 1 | 2021 | 2 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2001 | 161 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 245 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1556 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 1718 | 0.040 |
Why?
|
| Ligands | 1 | 2001 | 493 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 65 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 182 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 761 | 0.040 |
Why?
|
| Cell Division | 2 | 2014 | 744 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 180 | 0.040 |
Why?
|
| Coleoptera | 1 | 1997 | 14 | 0.030 |
Why?
|
| Protein Binding | 1 | 2001 | 1730 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 309 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 1038 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 167 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 196 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 304 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 813 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 408 | 0.030 |
Why?
|
| Cell Movement | 2 | 2014 | 891 | 0.030 |
Why?
|
| Osteopontin | 1 | 2014 | 51 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 107 | 0.030 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 62 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 1354 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 239 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 137 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 327 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2015 | 200 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 263 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2014 | 359 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 1426 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 691 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1997 | 995 | 0.020 |
Why?
|
| Organoids | 1 | 2014 | 301 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4540 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 6455 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1997 | 1581 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 774 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 701 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 636 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 2406 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1879 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1018 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1975 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2007 | 240 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 210 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 2903 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 990 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 13012 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 1394 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 158 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2003 | 23 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 85 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2003 | 51 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 268 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 381 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 305 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 383 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2003 | 170 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 387 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 237 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2002 | 156 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 3062 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 364 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 6238 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 9935 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 797 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3779 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 31599 | 0.010 |
Why?
|